Close menu




August 31st, 2021 | 13:11 CEST

Veolia, Memiontec, JinkoSolar, Alibaba - Green shares on the buy list!

  • Investments
Photo credits: pixabay.com

Politics is going its own way with the climate protocol from Paris. In addition to climate protection, many government programs also include keeping necessary life resources clean, such as air and water. Environmental protection is usually associated with higher costs in industry and must be mandated by law to ensure that the necessary measures are implemented consistently. In Europe, we are already well advanced with such climate laws with the CO2 tax. In other countries, it is taking a little longer. The US has been behind since Donald Trump, but this should be made up for under Joe Biden. We take a look at well-known environmental stocks and their opportunities.

time to read: 4 minutes | Author: André Will-Laudien
ISIN: VEOLIA ENVIRONNE. EO 5 | FR0000124141 , Memiontec Holdings Limited | SGXE56008290 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007 , ALIBABA GR.HLDG SP.ADR 8 | US01609W1027

Table of contents:


    Veolia SA - A benchmark in the water industry

    Veolia SA (formerly Vivendi Environnement) specializes in water, wastewater, waste management and energy supply. Formerly a state-owned public service company, Veolia has undergone several changes and has also been known as Générale des Eaux (CGE) or Suez. Today, the Group employs around 171,000 people and operates in 38 countries; its history dates back to 1853.

    Veolia's core "Water and Wastewater" division specializes in outsourcing water and wastewater services for municipal facilities and industrial customers. Here, Veolia provides engineering, design and execution of construction projects for the production and supply of drinking water, wastewater disposal networks, desalination plants and wastewater treatment plants, and their maintenance and repair. The Energy Services sector offers services to optimize energy efficiency, the economical production of renewable energy and the reduction of C02. In 2020, the Veolia Group supplied drinking water to around 120 million people and disposed of their wastewater and waste. Its waste management, water management, and energy services activities in Germany are concentrated in Veolia Deutschland GmbH, based in Berlin.

    The environmental services of the Veolia Foundation are outstanding. It maintains green non-profit projects in France and abroad with a focus on "sustainable development". Its main fields of activity are the environment, solidarity and professional integration. Since its creation in 2004, the foundation has helped with more than 1,000 projects worldwide, providing financial and human support through volunteers and assisting with humanitarian missions.

    In 2020, Veolia had revenues of EUR 27 billion and a net income of approximately EUR 950 million. The dividend yield is a lush 4%. The sustainable orientation of the Group also pleases investors, as the environmental standard value has already increased by 41% in 12 months.

    Memiontec - Water treatment for Asia

    With Memiontec Holdings Ltd., we find a Singapore-based company whose focus covers all areas of water treatment and purification. For more than 20 years, the Company has provided water and wastewater-related services throughout Singapore, Indonesia and the People's Republic of China. In Indonesia, Memiontec has leveraged its more than 20 years of business presence to diversify into the water supply sector through TOOT and BOOT projects with public or private organizations since 2016. With the entire value chain in the water segment, the Indonesian-based Company is one of the first contacts for local disposal concepts.

    Depending on the type of contamination, Memiontec works with the help of membranes, ion exchangers or a combination of physical, chemical and biological process chains in water purification. Customers are mainly municipalities and larger industrial companies. With good setups in Singapore and Indonesia, the Company's growth target is to provide its environmental services to a wide range of neighboring countries in Asia.

    Currently, it is reported that the water solutions specialist has now won two new tenders worth a total of SGD 12.7 million from Singapore's Public Utilities Board. In April, the Company had already been able to book tickets worth SGD 21.7 million. The Group's order book now stands at around SGD 91.6 million as of July 31, 2021. Memiontec anticipates that there will be several significant public tenders in Singapore over the next two years, which will positively impact the Group's growth.

    The Memiontec share price reacted to the good news with a jump. The price rose by a full 50% from SGD 0.24 to SGD 0.36 within just 5 trading days. The share is also listed in Frankfurt and Stuttgart. The story is now getting more and more attention and fits into any sustainable growth portfolio because of its green focus.

    JinkoSolar - Taken to task with Alibaba & Co.

    Chinese shares are currently not having an easy time because the regulator has looked at business models of successful companies with a USA listing. Internet giants Alibaba, Tencent, Baidu and Co., have thus had to shut down or make lasting changes to business units due to various public requirements. It has resulted in an average share price drop of more than 50%.

    The very successful JinkoSolar was even taken to task, even though its business model is more concerned with environmental protection and energy efficiency. However, the thumbscrews on the web giants should be somewhat secondary for the manufacturer of solar modules, yet the poor investment climate also affects Jinko.

    Now the solar giant is introducing a new PV module. At the beginning of the year, the Group had started to produce the monocrystalline solar modules. Some details have been announced about the solar module "Tiger Neo", which will be launched on the market soon. Its efficiency ranges from 21.11 to 22.18%, with a linear degression of power of 0.40% over a full 30 years. In the first year, the performance deteriorates by less than 1%. With these framework parameters, the new module is expected to be a best seller.

    JinkoSolar is currently in the top Group of module producers; moreover, the Company has a solid technological position. Growth should therefore continue unabated as many governments will not roll out green infrastructure programs until 2022. The stock lost over 50% in the China correction from January to May and is now catching up! 20% plus in just one week is quite a feat, though, so act on weak days.


    Not every green stock has what it takes to be a good investment story, as seen in the overpriced hydrogen stocks. Our selection includes solid growth stocks with good medium-term prospects. Veolia and JinkoSolar are relatively well-known standard stocks. The much smaller Memiontec is well-positioned and growing well.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read